FDA
-
-
-
-
-
-
-
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance
-
-
-
-
-
-
-
VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
-
-
-
-
-
-
-
VTRS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
-
-
-
-
-
-
-
VTRS SECURITIES UPDATE: Viatris Inc. Investors with Losses are Reminded of the Upcoming June 3 Securities Class Action Deadline
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

